Chlorozotocin

Chlorozotocin
Clinical data
ATC code	none;
Identifiers
	IUPAC name 1-(2-Chloroethyl)-1-nitroso-3-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea;
CAS Number	54749-90-5 ;
PubChem CID	451706;
ChemSpider	397854 ;
UNII	3053LTY75Z;
KEGG	C19170 ;
ChEMBL	ChEMBL2094020 ;
CompTox Dashboard (EPA)	DTXSID9020320 ;
Chemical and physical data
Formula	C9H16ClN3O7
Molar mass	313.69 g/mol g·mol−1
3D model (JSmol)	Interactive image;
	SMILES ClCCN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO;
	InChI InChI=1S/C9H16ClN3O7/c10-1-2-13(12-20)9(19)11-5(3-14)7(17)8(18)6(16)4-15/h3,5-8,15-18H,1-2,4H2,(H,11,19)/t5-,6+,7+,8+/m0/s1 ; Key:MKQWTWSXVILIKJ-LXGUWJNJSA-N ;
	(what is this?) (verify)

Chlorozotocin is a nitrosourea. It is used for cancer therapy.^{[citation needed]}

It is an analogue of streptozotocin.^[1]

References

^ Wolfe, M. Michael (2006). Therapy of digestive disorders. Elsevier Health Sciences. pp. 477–. ISBN 978-1-4160-0317-5. Retrieved 31 July 2011.

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.